Introduction
PLA 2 isoenzymes are broadly classified in three groups, secretory (sPLA 2 ), cytosolic (cPLA 2 ) and Ca 2 + -independent isoforms (iPLA 2 ). [1] All isoforms cleave the sn-2 acyl chain of phospholipids to generate a fatty acid and a lysophospholipid. Both molecules can have signaling functions. [2] In particular, the release of arachidonic acid by cPLA 2 leads to early inflammatory responses. Therefore PLA 2 s are important mediators in cell function and their activity has implications in various diseases. [3, 4] The physiological roles of many PLA 2 isoforms, in particular the secreted ones, are not clearly understood to date. There is evidence that, after re-internalization, some sPLA 2 isoforms, most notably group V PLA 2 , participate in the release of arachidonic in a cPLA 2 -dependent as well as an independent way. [5] [6] [7] [8] To further elucidate the distinct roles of the different isoforms, it would be helpful to have access to probes that are selectively hydrolyzed by only one particular isoform.
Intracellular enzyme activities, including those of PLA 2 s, can be measured by fluorescent probes based on FRET between a donor fluorophore and a FRET acceptor. [9] The latter could be a quenching dye or a fluorophore. In the second case, sensitized emission after FRET can be used for ratiometric measurements. Because they are bound in the same molecule, the two corresponding fluorophores are present in a defined ratio, typically 1:1. This ensures that ratio measurements of the two emission intensities can be performed nearly independently of the probe's concentration.
The vast majority of FRET probes that are available today are based on fluorescent proteins from jellyfish or corals and are genetically encoded. [9] [10] [11] Unfortunately, most of these probes exhibit FRET changes in the range of only 10-100 %, although there are exceptions. [12] This is large enough to be very useful for studying cell biology in living cells, but is limiting when the probes need to be developed into assays that are suitable for high-throughput screening (HTS). The latter is shifting to a significant degree towards cell-based assays making FRET probes with large ratio changes very desirable. Larger FRET changes should be easier to achieve by probes that are based on small molecules, simply because the fluorophores are usually in closer proximity; this permits a higher initial FRET efficiency and therefore results in a large dynamic range. Furthermore, the outcome of the manipulation is more predictable. In addition, small fluorophores usually have the advantage of being able to rotate freely; this results in FRET changes that depend solely on distance alterations. In pioneering work, Zlokarnik et al. used this principle together with doubly labeled cephalosporin derivatives (CFF-2) that functioned as a sensor for b-lactamase activity. [13] This system found wide application in reporter gene assays for the screening industry. The change in the emission ratio was about 70-fold, which is very suitable for applications that involve cell-sorter experiments.
Generally, all hydrolytic enzymes are attractive targets for small-molecule sensors because, after enzymatic hydrolysis, the fragments separate infinitely, thereby eliminating energy transfer. Up to now, most work has been done on substrates for proteinases and lipases. For phospholipases, including those for phospholipase A 2 activity, fluorogenic probes were introduced some time ago. [14] [15] [16] [17] [18] However, these probes were used for in vitro experiments, a few cell experiments, [18, 19] and were injected into fish-embryos [20] or administered to the gastrointestinal tract of animals, which is readily accessible. [21] Another attempt to deliver a FRET sensors into cells employed liposomes. [17] Very recently, we developed the small-molecule FRET probe PENN (1) that monitored phospholipase A 2 activity in living cells when used as a membrane-permeant derivative. [22] The probe was based on a phosphatidylethanolamine derivative with the FRET donor (NBD) and the FRET acceptor (Nile Red) attached to the w-CH 2 groups of the lipid chains (Scheme 1). Upon hydrolytic cleavage by bee venom sPLA 2 the probe exhibited a~20-fold emission-ratio change. We also introduced a membrane-permeant bioactivatable derivative of the probe (2) in which charged moieties were masked with Sacyl-thioethyl (SATE)-groups. [23, 24] This reporter performed well in cells and small organisms. Cell entry was very rapid and led to a localization of the probe in microsomal membranes. Although the probe was fully hydrolyzed in HeLa cells in about 30 min, PENN was not a substrate for the physiologically important cytosolic PLA 2 (cPLA 2 a) in vitro. Because cPLA 2 a prefers substrates with a sn-2 arachidonyl chain, [25, 26] we attributed the poor activity of PENN to a lack of double bonds in the sn-2 acyl chain. We therefore intended to alter the sn-2-fatty acid into a better mimic of arachidonic acid, while maintaining the fluorophore composition. Our target molecules were derivatives of PENN that bore the first (PENN2, 3), or the first three double bonds (PENN3, 7) of arachidonic acid as well as their respective membrane-permeant bisA C H T U N G T R E N N U N G (SATE) esters 4 and 8 (Scheme 1). For synthetic reasons, the fluorophores in PENN3 were attached in a way that NBD was coupled to the arachidonic acid mimic, while in PENN and PENN2 the cleavable fatty acid carried Nile Red.
Results

Synthesis
One of the main difficulties in synthesizing arachidonic acid derivatives is the all-Z configuration of the double bonds. Because separations of Z/E isomer mixtures are often very tedious or even impossible, reactions are needed that produce none of the undesired isomer. For instance, Wittig reactions were not suitable in our hands, although the major products showed the desired Z configuration. For the synthesis of PENN3 (7), we therefore employed copper-mediated coupling reactions between terminal alkynes and propargyl halides, [27] as was previously described for the synthesis of anandamide (arachidonylethanolamide) analogues. [28] Reduction with Lindlar catalyst was ultimately successful to generate exclusively Z trienes (Schemes 2 and 3). Scheme 1. Structures of PLA 2 -sensitive phospholipids PENN (1), PENN2 (3), PMNN2 (5), and PENN3 (7), as well as the membrane-permeant derivatives protected by S-acetyl thioethyl (SATE) groups.
For preparing a labeled fatty acid with one Z double bond, we decided to attach Nile Red as a fluorophore, as in PENN (1), because we expected a NBD-tagged heptenoic acid to be too hydrophilic to stay in membranes. Furthermore, our anticipated synthetic pathway (Scheme 2) would involve a catalytic hydrogenation in the presence of the fluorophore, which is better tolerated by Nile Red than NBD. 4-Bromobutyric acid (9) was coupled with tetrahydropyran (THP)-protected propargyl alcohol in the presence of butyllithium in a standard substitution reaction. The resulting THP-protected hept-5-ynoic acid 10 was quantitatively deprotected by acidic catalysis in methanol. Simultaneously, the carboxyl function was esterified to the methyl ester to give hydroxyheptenoic acid methyl ester 11.
The hydroxyl group was substituted by bromide in an Appelt reaction to yield 12, and subsequently Nile Red was coupled to form fatty acid ester 13. Hydrogenation over Lind-A C H T U N G T R E N N U N G lar catalyst in the presence of quinoline afforded heptenoic acid ester 14. It is known from previous unpublished work and other groups that hydrolysis of esters under basic conditions can damage Nile Red. [29] Thus, we successfully removed the ester by treatment with pig liver esterase in phosphate-buffered saline (PBS) buffer at pH 7.4 without harming the dye. [30] Fatty acid 15 was then coupled to the already described sn-2 alcohol 16 to generate the protected glycerol derivative 17.
Removal of the DMT group with DOWEX WX8 resin as a mild solid-phase-bound acid gave alcohol 18, which was phosphitylated with reagents PI, PII, or PIII (Scheme 4) in the presence of 4,5-dicyanoimidazol (DCI) as a mediator, respectively, [31] followed by in situ oxidation with tert-butylhydroperoxide and, if necessary, deprotection to yield the charged probe PENN2 (3), or PENN2/SATE (4) and PMNN2/SATE (6) . All probes were purified by HPLC or by preparative thin layer chromatography. For in vitro experiments, a small sample of PMNN2/SATE (6) was deprotected by treatment with lipase from Candida cylindracea to yield PMNN2 (5) .
For the preparation of the labeled and triple-unsaturated fatty acid 27 (Scheme 3), the use of NBD as the fluorophore was required (see below). The reaction sequence started from 5-hexynoic acid 19 which was protected by esterification with trimethylsilylethanol in the presence of diisopropylcarbodi-A C H T U N G T R E N N U N G imide (DIC). The resulting ester 20 was treated with an excess of 1,4-dichlorobut-2-yne in the presence of two equivalents of CuI to furnish diyne 21. The latter was subsequently coupled to but-3-yn-1-ol under identical conditions. Both reactions gave only modest yields, as was described previously. [20] Reduction of triyne 22 with Lindlar catalyst gave exclusively triene 23 in good yield. Substitution of the alcohol group to the azide 24 under Mitsunobu conditions and subsequent reduc-tion afforded amine 25, [32, 33] which was successfully labeled with NBD in 72 % yield. Deprotection of fluorescent compound 26 by TFA gave tetradecyltrienoic acid derivative 27. All efforts to prepare Nile-Red-labeled trienoic acids starting from 23 resulted in decomposition of the triene.
The phosphatidylethanolamine backbone was prepared from the known sn-3-bromododecylether 28 (Scheme 4). [14] Direct alkylation of Nile Red gave the 2'-O-Nile-Red-labeled compound 29, which was protected at the primary alcohol group by forming the dimethoxytrityl (DMT) ether 30. The latter was successfully coupled to 27 with 1-(2,4,6-triisopropylbenzenesulfonyl)-3-nitro-1H-1,2,4-triazole (TPSNT) and methylimidazole (MeIm) in 79 % yield.
The doubly labeled glycerol derivative 31 was deprotected and the resulting alcohol 32 was phosphitylated either with reagent PI or the SATE-protected reagent PII, this was followed by mild in situ oxidation. In case of PENN3 (7) subsequent removal of the protecting groups by 10 % TFA in dichloroA C H T U N G T R E N N U N G meth-A C H T U N G T R E N N U N G ane gave the deprotected phosphoethanolamine derivative. The SATE protected derivative 8 and 7 were purified as previously described for PENN2 and PENN2/SATE, respectively.
Biochemistry
To compare the performance of the new sensors with PENN, we examined their sensitivity to various sPLA 2 s in vitro. We chose a set of commercially available enzymes from different subfamilies; these ranged from PLA 2 s derived from animal poisons, pancreatic juices, and bacterial origin to human group V sPLA 2 . From a pharmacological point of view, the latter is the most interesting and important because it is known to be involved in inflammatory processes by releasing arachidonic acid extra-as well as intracellularly. [8] Group V sPLA 2 -induced arachidonic acid release is known to occur in concert [5, 7] as well as independently [6] from cytosolic PLA 2 (group IV), and is therefore considered to be another important key player in inflammation; this finding is further supported by studies with gene knock-out mice. [34] Micelles of Triton X-100 (3 mm in Tris-HCl, pH 8.6) were prepared by sonication and were spiked with the sensor of interest. The dye concentration was kept at 1 mm, which corresponds to one molecule per~20 micelles, to avoid intermolecular energy transfer. Addition of the sPLA 2 started the reaction, which was monitored by an increase in NBD-and a decrease in sensitized Nile Red fluorescence (Figures 1 A-D) . All four sensors exhibited similar behavior with respect to the increase in NBD fluorescence, but they differed with respect to kinetic A C H T U N G T R E N N U N G parameters. PENN2 was the most widely accepted sensor for sPLA 2 s and exhibited, in most cases, the fastest kinetics. As is shown for the example of human group V PLA 2 in Figures 2 and 3, PENN2 (3) is by far the favored substrate of this enzyme. Hog pancreatic PLA 2 predominantly accepts PMNN2 (5). These selectivities might be useful to monitor isoenzymespecific catalysis in the future. As expected, bee venom PLA 2 was the most potent enzyme; cleaving all substrates without preference. The next most potent enzyme was Naja mossambica mossambica venom PLA 2 .
For applications in living cells, we tested if the hydrolysis of bioactivatable protecting groups is required to produce PLA 2 substrates. PENN/SATE (2) was added to Triton X-100 micelles. When incubated with bee venom PLA 2 , no significant hydrolysis was monitored until an unspecific lipase from C. cylindracea was added. The latter hydrolyzed the SATE group off of the phosphate; this made the probe a substrate for the PLA 2 , which was indicated by the onset of ratio change ( Figure 4 ). The other sensors exhibited similar properties. The lipase itself had no effect on the ester at the sn-2 position, but subsequent addition of PLA 2 gave rapid cleavage. This suggested that the deprotection of bioactivatable protecting groups might be the rate-limiting step when endogenous PLA 2 levels are monitored in living cells.
It was previously shown that HeLa cells that have been stimulated with fetal calf serum have an endogenous PLA 2 activity that can be measured with PENN/SATE (2). [22] For example, 2 was cleaved within 30 min when administered to the cells in the presence of serum. In order to compare our novel probes to PENN/SATE, HeLa cells were incubated for 30 min in the presence or absence of 5 % fetal calf serum (FCS) and the amount of hydrolysis was shown by the overlay of the NBD and the Nile Red fluorescence. Stimulated cells that were incubated with PENN/SATE showed a stronger green signal than those that were treated with PENN2/SATE or PENN3/SATE. The latter gave only a very weak signal ( Figure 5 ).
This result supports previous findings that led to the hypothesis that platelet-activating factor acetyl hydrolase 2 (PAF-AH2) is responsible for probe turnover in HeLa cells. [22] This enzyme predominantly cleaves shorter fatty acids (preferably acetate) as well as oxidatively damaged chains from the sn-2 position. [35, 36] Here PENN has advantages over the other probes, which could explain the lack of hydrolysis of PENN3 and the reduced cleavage of PENN2. As expected from the in vitro experiments, stimulation with reagents that elevate intracellular calcium levels like ionomycin and bromo-A23187 were not able to activate probe hydrolysis. This confirms the lack of Figure 2 . The acceptance of PLA 2 substrates PENN2 (3, dotted curve), PMNN2 (5, dash-dot) and PENN (1, straight) by human PLA 2 group V differed markedly. This demonstrates that this secretory isoform is preferentially monitored by PENN2. Probes were taken up in Triton X-100 assay buffer (pH 8.6; final concentration 1 mm), transferred to a 384-well plate (50 mL per well) and treated with enzyme. substrate properties of all probes for calcium-activated cytosolic phospholipases like cPLA 2 a.
Discussion
Copper-mediated coupling reactions proved to be very useful for preparing fluorescently labeled arachidonic acid mimics. A C H T U N G T R E N N U N G Incorporation of these fatty acids readily gave doubly labeled phosphatidylethanolamine derivatives that exhibited sensitized emission in a comparable range. Charged sensors (1, 3, 5, 7) gave similar endpoint spectra after complete hydrolysis. Only PENN3 (7) with NBD attached to the fatty acid showed a twofold lower NBD emission, potentially due to the higher solubility in water and therefore reduced quantum yield. [37] All SATE esters (2, 4, 6, and 8) readily entered cells. Furthermore, we demonstrated the release of PLA 2 substrates from the SATE precursors by the action of unspecific lipases.
The new PLA 2 substrates presented in this paper might serve as valuable sensors for pharmacologically important members of the PLA 2 family in vitro. In particular the group V PLA 2 is interesting in this respect, because it is of physiological relevance, it shows a strong preference for only one of the reporters (PENN2), and it is known to act inside living cells. [8] It seems to be feasible to expose a set of FRET sensors to a given biological sample to determine the isoform activity by comparing substrate cleavage patterns. Inside living cells, it remains to be shown whether group V PLA 2 activity can be monitored, for instance after overexpressing the enzyme. Unfortunately, none of the probes showed improved properties towards the pharmacologically interesting cPLA 2 a in vitro. Most likely, the fluorophores are interfering with the catalytically productive binding to the active site of cPLA 2 a. Potentially, the tolerance of the enzyme might be stretched by adding bulky or partially polar fluorophores to the fatty acids. Future experiments might require having all four double bonds of arachidonic acid available. Furthermore, the replacement of the PENN head group by phosphatidylglycerol might improve the acceptance of the sensors by this enzyme. [38] It cannot be excluded that the ether linkage in the sn-1 position is preventing enzymatic hydrolysis by the enzyme variant that we were probing, although the acceptance of sn-1 ethers was previously described. [12] In living cells, the shorter probe, PENN, is still the bestaccepted substrate. This suggests that an alignment of in vitro and in vivo results so far gives misleading answers. Apparently, it is necessary to generate more specific fluorogenic substrates and to identify so-far-uncharacterized phospholipase activities in target cells.
Experimental Section
General methods: Unless otherwise noted, materials were obtained from commercial suppliers in the highest purity available and were used without further purification. Dry solvents were purchased from Fluka, stored over molecular sieves, and used as supplied. Purified enzymes were purchased from Sigma (PLA 2 from Streptomyces violaceoruba and Naja mossambica mossambica), Fluka (Lipase from C. cylindracea and PLA 2 from Hog pancreas as well as honey bee venom or Cayman Chemicals (human Group V sPLA 2 ; Ann Arbour, MI). Flash chromatography was carried out by using Merck silica gel 60 (63-200 mesh). Analytical TLC was A C H T U N G T R E N N U N G performed on Merck silica 60 WF 254s analytical plates with ethyl A C H T U N G T R E N N U N G acetate/cyclohexane or methanol/methylene chloride mixtures as eluents. Spots were detected by a UV hand lamp at 254 nm or 366 nm or by staining with either phosphomolybdic acid/cerium(IV) sulfate reagent, ninhydrin solution, or anisaldehyde/sulfuric acid-reagent. Preparative TLC was carried out on 20 cm 20 cm 2 mm Merck silica glass plates using the same eluent mixtures.
NMR spectra were recorded using a Bruker UltraShield TM Advance 400 spectrometer (400 MHz, 1 H; 100 MHz, 13 C; 162 MHz, 31 P) and calibrated by using residual non-deuterated solvent as an internal reference.
High-resolution mass spectra were recorded at University of Heidelberg by using either fast atom bombardment (FAB) or Electron Impact (EI) mass spectrometry on a Jeol JMS 700 mass spectrometer. Electrospray mass spectra were recorded on an ESI-Q-TOF Ultima API (Micromass/Waters) mass spectrometer.
Fluorescence spectra were recorded with a Quantamaster QM4/ 2000SE (Photon Technology International, Birmingham, NJ) fluorimeter by using 1 mL disposable plastics cuvettes. Assays were performed in a Tris-HCl-buffered Triton X-100 mixed micelle system at pH 8.6 and 37 8C (100 mm KCl, 10 mm CaCl 2 , 25 mm Tris-HCl, 3 mm Triton X-100). Excitation wavelength was 458 nm. Emission spectra were recorded from 470 nm to 750 nm with 2 nm step size.
Kinetics were measured in 384-well clear-bottom plates (Costar) in an EnVision (Perkin-Elmer) plate reader at room temperature. For the assay, the same Triton-based buffer mentioned above was used. Excitation was at 458 nm (30 nm bandwidth), NBD emission was measured at 535/35 nm, Nile red emission with a 630/40 nm filter.
Fluorescence microscopy was carried out on a Zeiss Axiovert 200M. Filter setup for NBD fluorescence was 460/50 excitation, 500DCLP dichroic mirror, D535/40 m emission; for Nile red fluorescence settings were 560/40 excitation, 595DCLP dichroic mirror, D630/60 m emission. Assays were performed in CO 2 -independent HEPES buffer that had been adjusted to pH 7.4 (115 mm NaCl, 1.2 mm CaCl 2 , 1.2 mm MgCl 2 , 2.4 mm K 2 HPO 4 , 20 mm HEPES).
Products were characterized by NMR spectroscopy ( 1 H, 13 C and if appropriate 31 P) and high resolution MS except PENN3, which did not yield sufficient material for reliable 13 C NMR data.
7-(Tetrahydro-pyran-2-yloxy)hept-5-ynoic acid (10): In a 100 mL Schlenk flask tetrahydropyran (THP)-protected propargylic alcohol (1.4 g, 10 mmol) was dissolved in dry THF (30 mL) under an atmosphere of dry argon. The mixture was cooled to À80 8C in an ethanol/liquid nitrogen bath and was treated with 2.2 equiv of n-butyllithium. After stirring for 20 min the solution was allowed to warm up to À20 8C and one equivalent of 4-bromobutyric acid (9) in DMSO (10 mL) was added via syringe. The mixture was stirred for another 6 h at this temperature until TLC (cyclohexane/ethyl acetate 3:2) showed no further progress of the reaction. Subsequently the reaction was quenched by the addition of methanol (5 mL), and was stirred for 15 min longer. The mixture was poured into phosphate buffer (pH 7), and was extracted three times with ethyl acetate. The combined organic layers were washed with brine, dried over Na 2 SO 4 and evaporated to dryness. The resulting brownish oil was subjected to silica column chromatography (cyclohexane/ethyl acetate 7:3). Product-containing fractions were pooled and evaporated under reduced pressure to yield the THP-protected heptynoic acid as a clear oil (859 mg, 3.8 mmol, 38 %). 7-Hydroxy-hept-5-ynoic acid methyl ester (11): The acid 10 (791 mg, 3.5 mmol) was dissolved in methanol (40 mL). Concentrated HCl (3 drops) were added, and the resulting reaction mixture was heated to reflux. To monitor the reaction, samples (100 mL) were taken, evaporated and the 1 H NMR spectrum of the residue was measured. After three hours, the THP signals disappeared completely, and the reaction was stopped by the addition of phosphate buffer (200 mL, pH 7). The mixture was transferred into a separation funnel and was extracted with ethyl acetate (3 50 mL). The combined organic layers were washed with brine and dried over Na 2 SO 4 . After evaporation under reduced pressure, the deprotected alcohol was isolated quantitatively (544 mg, 3.5 mmol) as a colorless oil. R f = 0. 23 7-(9-Diethylamino-5-oxo-5H-benzo[a]phenoxazin-3-yloxy)hept-5-enoic acid methyl ester (14) : Under an atmosphere of dry argon alkyne 13 (378 mg, 0.80 mmol) was dissolved in dry THF (10 mL). Lindlar catalyst (10 mol %) and chinolin (10 mL) were added and the argon was exchanged by hydrogen. The deep-red solution was stirred until the color changed to a greenish yellow (approximately 30 min), which indicated that the reduction of the fluorophore was complete. At that time, the hydrogen was removed. Contact with air reoxidized the Nile red immediately, and the red color returned. The catalyst was removed by filtration via Celite, and the solvent was removed under reduced pressure. The resulting crude alkene was then further purified by silica column chromatography (dichloromethane/methanol, 100:0!98:2) to yield the pure product as a red amorphous solid (367 mg, 96 %). R f = 0.31 (cyclohexane/ ethyl acetate 3:2); 
Three flame-dried, argon flushed, rubber septum sealed 50 mL-flasks were prepared, containing: a) methylimidazole 3 equiv (48 mL, 600 mmol); b) TPSNT 1.5 equiv (114 mg, 300 mmol); c) NBD-labeled glycerol derivative 16 (223 mg, 200 mmol) and a stirring bar. 1.5 equiv of the Nile red labeled acid 15 (139 mg, 300 mmol) was dissolved in dry dichloromethane (10 mL). The solution was taken up by a syringe and injected into flask a. After shaking this mixture for 30 seconds, it was taken up with the same syringe and injected into flask b to get the activated acid. This solution was then immediately transferred to flask c, and was stirred for 11-14 h at room temperature. The solvent was removed in vacuo, and the resulting 13 C NMR (100 MHz, CDCl 3 
The DMT-protected glycerol 17 (81 mg, 86 mmol) was dissolved in dichloromethane (10 mL). Dried DOWEX-50 WX-8 (350 mg) resin was added and the flask was mounted on a rocking platform and shaken for 4 h at room temperature. After this time, the resin was filtered off and the solvent was removed under reduced pressure. The remaining crude mixture was then purified by silica column chromatography with a stepwise gradient (100 %!98 %, 0.5 % steps) of dichloromethane/ methanol to yield of the pure deprotected glycerol as a red wax (41 mg, 69 %). R f = 0.06 (cyclohexane/ethyl acetate 3:2); Hex-5-ynoic acid 2-trimethylsilanylethyl ester (20) : Under an atmosphere of dry argon, 5-hexynoic acid 19 (2.8 g, 25 mmol) was dissolved in dichloromethane (70 mL). 2-Trimethylsilylethanol (3.55 g, 30 mmol) and DIC (5.04 g, 40 mmol) were added and the mixture was stirred at room temperature overnight for 15 h. After this time, the TLC showed complete consumption of the acid. The precipitated diisopropylurea was filtered off. The filtrate was poured into saturated Na 2 CO 3 solution and was extracted three times with dichloromethane. The combined organic layers were washed with brine, dried over Na 2 SO 4 and evaporated to dryness at the rotary evaporator under reduced pressure. The remaining oil was purified by silica column chromatography (cyclohexane/ethyl acetate 8:2). Product-containing fractions were pooled and evaporated under reduced pressure to yield the protected acid as a clear oil (5 10-Chloro-deca-5,8-diynoic acid 2-trimethylsilanylethyl ester (21): A mixture of K 2 CO 3 (20 mmol, 2.76 g), CuI (20 mmol, 3.81 g), NaI (20 mmol, 3.00 g), the TMSE protected hexynoic acid 20 (20 mmol, 4.2 g) and 1,4-dichlorobutyne (80 mmol, 7.4 g) in DMF (60 mL) was stirred overnight at room temperature. The mixture was diluted with ethyl acetate and filtered through a pad of Celite to remove the copper salts. The resulting solution was washed with NH 4 Cl (4 100 mL) and brine. The organic layer was dried over Na 2 SO 4 and all volatile compounds were removed in vacuo after filtration. The residue was purified by silica column chromatography (cyclohexane/ethyl acetate 9:1!7:3) to give the diyne as slightly yellowish oil (3.11 g, 52 %). R f = 0.54 (cyclohexane/ethyl acetate 3:2); 14-Hydroxy-tetradeca-5,8,11-triynoic acid 2-trimethylsilanylethyl ester (22) : A mixture of K 2 CO 3 (1.24 g, 9 mmol), CuI (1.71 g, 9 mmol), NaI (1.35 g, 9 mmol), the TMSE protected hexynoic acid 21 (2.69 g, 9 mmol) and 4-butynol (700 mg, 10 mmol) in DMF (30 mL) was stirred overnight at room temperature. The mixture was diluted with ethyl acetate and filtered through a pad of Celite to remove the copper salts. The resulting solution was washed with NH 4 Cl (4 50 mL) and brine. The organic layer was dried over Na 2 SO 4 and all volatile compounds were removed in vacuo after filtration. 14-Amino-tetradeca-5,8,11-trienoic acid 2-trimethylsilanylethyl ester (25): 3 equiv Ph 3 P (1.18 g) and a drop of water were added to a stirred solution of the azide 24 (545 mg, 1.5 mmol) in THF (10 mL). Immediately gas bubbles formed, which indicated the start of the reaction. The mixture was stirred for 3 h at RT, until TLC analysis showed complete consumption of the azide, and a new ninhydrin-active spot (R f = 0) was observed. The solvent was removed under reduced pressure, and the residue was subjected to short column silica chromatography. Ph 3 P and impurities were eluted with cyclohexane/ethyl acetate (7:3). Then the eluent was switched to cyclohexane/ethyl acetate/dimethylethylamine (6:4:0.1) to wash off the pure amine as a colorless oil (315 mg, 62 %). 14-(7-Nitrobenzooxadiazol-4-ylamino)tetradeca-5,8,11-trienoic acid 2-trimethylsilanylethyl ester (26) : Amine 25 (260.2 mg, 771 mmol) in methanol (2 mL) was added dropwise to a stirred solution of NBD-chloride (160 mg, 800 mmol) and DIPEA (5 equiv) in dry methanol (10 mL), at 0 8C. After complete addition, the mixture was stirred for further 3 h at 0 8C. 
A catalytic amount of DMAP and Et 3 N (210 mL, 1.5 mmol,) in DMF (20 mL) as well as DMTCl (372 mg, 1.1 mmol) were added to a stirred solution of the Nile-red-labeled glycerol (592 mg, 1 mmol). The solution was stirred overnight until TLC analysis (dichloromethane/methanol 95:5) showed no further progress of the reaction. The solution was diluted with ethyl acetate and was washed with 10 % NaHCO 3 (3 60 mL) and brine (2 50 mL). The organic layer was dried over Na 2 SO 4 , and the solvent was evaporated under reduced pressure.
To remove residual DMF, the resulting deep red slurry was taken up with methanol, and the DMT-labeled raw product was precipitated by dropwise addition of water. The precipitate was collected by filtration and dried overnight in a desiccator over P 2 O 5 under A C H T U N G T R E N N U N G reduced pressure. The resulting crude product was subjected to silica column chromatography (cyclohexane/ethyl acetate 3:2 + 1 % Me 2 NEt). The product containing fractions were pooled and evaporated to dryness in vacuo to yield the DMT protected glycerol as a deep red powder (528 mg, 0.59 mmol, 59 %). To recover the starting material, the column was washed with (dichloromethane/ methanol 95:5) to furnish the unprotected glycerol (233 mg, 39.3 %). The combined overall yield was 98 %. R f = 0. (32) : According to the procedure for 18, the DMT protected lipid 31 (127 mg, 100 mmol) was dissolved in dry A C H T U N G T R E N N U N G dichloromethane (5 mL), of DOWEX-50 WX-8 resin (400 mg) was added, and the mixture was shaken for 4 h. After purification on silica gel (dichloromethane/methanol 99.5!98 %) the deprotected glycerol was isolated as a red oil (70.3 mg, 72 mmol, 72 %). R f = 0.30 (dichloromethane/methanol 95:5); 24 H; CH 2 chain (9 ), NCH 2 CH 3 (2 )); 13 General phosphorylation procedure: The alcohol (1 equiv) and 4,5-dicyanoimidazole (4 equiv) were placed into a Schlenk flask. The flask was sealed with a rubber stopper. Dry acetonitrile was added and evaporated in vacuo three times to remove traces of water azeotropically. DMF was added under an atmosphere of dry argon, and the mixture was cooled to 0 8C. The phosphoramidite (2 equiv) was added, and the mixture was stirred overnight. After 12 h, TLC (dichloromethane/methanol 95:5) showed a faster migrating spot of the phosphorousA C H T U N G T R E N N U N G (III) triester which could not be isolated. Instead, the whole reaction mixture was cooled to 0 8C and treated with an excess of tBuOOH for 1 h to oxidize to the stable phosphorous(V) triester. The products were either isolated in case of SATE-protected derivatives or further treated to give the free phosphatidylethanolamine derivatives. According to the general procedure, the sn-3 alcohol 18 (38 mg, 39 mmol) was treated with 4,5-dicyanoimidazole (20 mg, 0.158 mmol) and the tert-butyl/Boc-protected phosphoramidite PI (30 mg, 0.080 mmol). The oxidation was performed by the addition of 5.5 m tBuOOH solution in nonane (50 mL). After 2 h all volatile compounds of the reaction mixture were removed under reduced pressure. The resulting t-butyl/Boc-protected phosphatidylethanolamine was not stable under flash chromatography conditions and was therefore deprotected to the desired final product by treatment with dichloromethane/TFA (90:10, 5 mL) for 50 min until TLC showed no further conversion (the product spot did not move in dichloromethane/methanol 95:5, but with 80:20 (R f = 0.46)). The dichloromethane/TFA mixture was removed under reduced pressure, and the resulting crude product was subjected to column chromatography (dichloromethane/methanol, 90:10!87:25). Product-containing fractions were combined, and the solvents were removed under reduced pressure to yield PENN2 (23 mg, 23 mmol, 59 %). sPLA 2 in vitro studies: A stock solution of each unprotected phosphatidylethanolamine probe (1, 3, 5, 7) was prepared in DMSO (10 mm) and adjusted to identical absorption at 450 nm. These stocks (0.5 mL) were diluted with the assay buffer (5 mL) to get a final concentration of 1 mm. This solution (1 mL) was placed into a disposable fluorimeter cuvette and fluorescence spectra were recorded at 37 8C until the system was equilibrated. Subsequently, 0.5 units of phospholipase A 2 from the indicated source were added, and spectra or timelapses were recorded over time.
For platereader experiments the same stock solutions were used. Aliquots (50 mL) of these were transferred to the wells in a 384-well clear-bottom plate. The indicated amount of enzyme was added, and fluorescence was measured overnight in 10 min intervals at room temperature. All measurements were performed in triplicates.
Live cell microscopy: A stock solution of 2 mm SATE-protected probe (2, 4, 6, 8) in DMSO/Pluronic (9:1) was prepared. This solution was diluted 1:1000 with HEPES buffer with or without 5 % FCS to prepare the final incubation solutions.
HeLa cells were plated in 4-chambered dishes and grown overnight to a confluence of about 40 %. The medium was taken off, and the PENNX/SATE-containing incubation buffers (0.5 mL) were placed into each chamber. After incubation with these solutions at &14& www.chembiochem.org 37 8C for 40 min, the buffer was removed, and the cells were washed with HEPES buffer (3 ). Finally they were monitored in the same buffer on a widefield microscope with a DAPI, NBD or Texas Red filter setup at room temperature.
SATE deprotection studies:
A solution PENN/SATE in DMSO (2 mL, 2 mm) was taken up in Triton X-100 assay buffer (4 mL) and sonicated for 5 min. Three disposable fluorescence cuvettes were filled with this solution (1 mL). The NBD and Nile red emission upon excitation at 458 nm was measured over time at 37 8C. The first cuvette was treated (t = 0 min) with 0.5 units of sPLA 2 from bee venom and subsequently with lipase from C. cylindracea (2 units, t = 40 min). In a second control cuvette PENN/SATE was not treated in the beginning, but after 40 min, 2 units of lipase were also added. This cuvette was further treated with 0.5 units of sPLA 2 from honey bee venom after 170 min.
Abbreviations
PENN is an abbreviation for phosphatidylethanolamine labeled with the dyes Nilered and NBD, PMNN is the corresponding phosphatidylmethanol derivative
